Search

CA Uyl‐de Groot

Cost-effectivness of CAR T-cell therapy for pALL. A societal view.
Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model.

Published with Wowchemy — the free, open source website builder that empowers creators.